These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 20854202

  • 1. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
    De Beaudrap P, Diallo MB, Landman R, Guèye NF, Ndiaye I, Diouf A, Kane CT, Etard JF, Girard PM, Sow PS, Delaporte E, ANRS 1215 Study Group.
    AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1221-7. PubMed ID: 20854202
    [Abstract] [Full Text] [Related]

  • 2. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
    Kamkuemah M, Kaplan R, Bekker LG, Little F, Myer L.
    Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
    [Abstract] [Full Text] [Related]

  • 3. Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.
    Young B, Buchacz K, Moorman A, Wood KC, Brooks JT, HIV Outpatient Study (HOPS) Investigators.
    AIDS Patient Care STDS; 2009 Aug; 23(8):589-92. PubMed ID: 19591609
    [Abstract] [Full Text] [Related]

  • 4. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
    Nishijima T, Kawasaki Y, Tanaka N, Mizushima D, Aoki T, Watanabe K, Kinai E, Honda H, Yazaki H, Tanuma J, Tsukada K, Teruya K, Kikuchi Y, Gatanaga H, Oka S.
    AIDS; 2014 Aug 24; 28(13):1903-10. PubMed ID: 25259702
    [Abstract] [Full Text] [Related]

  • 5. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.
    Mulenga L, Musonda P, Mwango A, Vinikoor MJ, Davies MA, Mweemba A, Calmy A, Stringer JS, Keiser O, Chi BH, Wandeler G, IeDEA-Southern Africa.
    Clin Infect Dis; 2014 May 24; 58(10):1473-80. PubMed ID: 24585558
    [Abstract] [Full Text] [Related]

  • 6. The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir.
    Young J, Wang Q, Fux CA, Bernasconi E, Furrer H, Vernazza P, Calmy A, Cavassini M, Weber R, Battegay M, Bucher HC, Swiss HIV Cohort Study.
    HIV Med; 2014 Sep 24; 15(8):505-10. PubMed ID: 24641488
    [Abstract] [Full Text] [Related]

  • 7. High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.
    Bonjoch A, Echeverría P, Perez-Alvarez N, Puig J, Estany C, Clotet B, Negredo E.
    Antiviral Res; 2012 Oct 24; 96(1):65-9. PubMed ID: 22892171
    [Abstract] [Full Text] [Related]

  • 8. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.
    Kinai E, Hanabusa H.
    AIDS Res Hum Retroviruses; 2009 Apr 24; 25(4):387-94. PubMed ID: 19361280
    [Abstract] [Full Text] [Related]

  • 9. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
    Wikman P, Safont P, Del Palacio M, Moreno A, Moreno S, Casado JL.
    Nephrol Dial Transplant; 2013 Aug 24; 28(8):2073-81. PubMed ID: 23739150
    [Abstract] [Full Text] [Related]

  • 10. Renal function with use of a tenofovir-containing initial antiretroviral regimen.
    Gallant JE, Moore RD.
    AIDS; 2009 Sep 24; 23(15):1971-5. PubMed ID: 19696652
    [Abstract] [Full Text] [Related]

  • 11. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.
    Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, Witt M, Diamond C, Haubrich R, Louie S, California Collaborative Treatment Group 578 Team.
    J Infect Dis; 2008 Jan 01; 197(1):102-8. PubMed ID: 18171292
    [Abstract] [Full Text] [Related]

  • 12. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
    Andrade-Fuentes K, Mata-Marín JA, López-De León JI, Manjarrez-Téllez B, Ramírez JL, Gaytan-Martínez J.
    AIDS Patient Care STDS; 2015 Apr 01; 29(4):181-5. PubMed ID: 25101526
    [Abstract] [Full Text] [Related]

  • 13. Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors.
    Pontrelli G, Cotugno N, Amodio D, Zangari P, Tchidjou HK, Baldassari S, Palma P, Bernardi S.
    BMC Infect Dis; 2012 Jan 23; 12():18. PubMed ID: 22269183
    [Abstract] [Full Text] [Related]

  • 14. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
    Quesada PR, Esteban LL, García JR, Sánchez RV, García TM, Alonso-Vega GG, Ferrández JS.
    Int J Clin Pharm; 2015 Oct 23; 37(5):865-72. PubMed ID: 26008219
    [Abstract] [Full Text] [Related]

  • 15. Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.
    Mugwanya KK, Wyatt C, Celum C, Donnell D, Mugo NR, Tappero J, Kiarie J, Ronald A, Baeten JM, Partners PrEP Study Team.
    JAMA Intern Med; 2015 Feb 23; 175(2):246-54. PubMed ID: 25531343
    [Abstract] [Full Text] [Related]

  • 16. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
    Huang YS, Chan CK, Tsai MS, Lee KY, Lin SW, Chang SY, Hung CC, Chang SC.
    J Microbiol Immunol Infect; 2017 Oct 23; 50(5):595-603. PubMed ID: 26514942
    [Abstract] [Full Text] [Related]

  • 17. Increased time exposure to tenofovir is associated with a greater decrease in estimated glomerular filtration rate in HIV patients with kidney function of less than 60 ml/min/1.73 m2.
    Fafin C, Pugliese P, Durant J, Mondain V, Rahelinirina V, De Salvador F, Ceppi C, Perbost I, Rosenthal E, Roger PM, Cua E, Dellamonica P, Esnault V, Pradier C, Moranne O.
    Nephron Clin Pract; 2012 Oct 23; 120(4):c205-14. PubMed ID: 23037894
    [Abstract] [Full Text] [Related]

  • 18. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG, Engsig FN, Feldt-Rasmussen B, Kirk O, Kronborg G, Pedersen C, Gerstoft J, Obel N.
    Scand J Infect Dis; 2012 Sep 23; 44(9):689-96. PubMed ID: 22680981
    [Abstract] [Full Text] [Related]

  • 19. Tenofovir disoproxil fumarate-associated nephrotoxicity in HIV-infected patients: a prospective controlled study.
    Woratanarat K, Kanjanabuch T, Suankratay C.
    J Med Assoc Thai; 2013 Apr 23; 96(4):432-9. PubMed ID: 23691697
    [Abstract] [Full Text] [Related]

  • 20. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
    Pradat P, Le Pogam MA, Okon JB, Trolliet P, Miailhes P, Brochier C, Maynard M, Bailly F, Zoulim F, Cotte L.
    J Viral Hepat; 2013 Sep 23; 20(9):650-7. PubMed ID: 23910650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.